Frequently Asked Questions
Q. On which exchange is Regenicin's stock traded, and what is its ticker symbol?
Q. What is Regenicin's Mission Statement? A: Regenicin, Inc. (OTC Bulletin Board: RGIN.OB), is a biotechnology company specializing in the development and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs. Regenicin, which was founded in 2010, has assembled a world class management team with a proven track record for developing and bringing innovative medical devices and biotechnology products to market. Regenicin is playing a critical role in the development of the therapeutic candidate, Regenicin cultured skin substitute, an exciting breakthrough technology that uses the patient's own skin cells to generate living, tissue-engineered skin for the treatment of catastrophic burns.
Q. What is Regenicin's Business Model?
Q. Where is Regenicin headquartered?
Q. When is Regenicin's fiscal year-end?